Genus PLC
OTC:GENSF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genus PLC
OTC:GENSF
|
UK |
|
Aurea SA
F:94P
|
FR |
|
R
|
Reservoir Media Inc
F:0RL0
|
US |
|
ME Therapeutics Holdings Inc
F:Q9T
|
CA |
|
C
|
Cheniere Energy Inc
XBER:CHQ1
|
US |
|
A
|
Akzo Nobel NV
OTC:AKZOF
|
NL |
Wall St Price Targets
GENSF Price Targets Summary
Genus PLC
According to Wall Street analysts, the average 1-year price target for GENSF is 46.499 USD with a low forecast of 37.562 USD and a high forecast of 56.661 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GENSF's stock price target?
Price Target
46.499
USD
According to Wall Street analysts, the average 1-year price target for GENSF is 46.499 USD with a low forecast of 37.562 USD and a high forecast of 56.661 USD.
What is the Revenue forecast for Genus PLC?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 4%.
What is the Gross Profit forecast for Genus PLC?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Genus PLC?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 4 years is 12%.
What is the Pre-Tax Income forecast for Genus PLC?
Projected CAGR
56%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -5%. The projected CAGR for the next 3 years is 56%.
What is the Net Income forecast for Genus PLC?
Projected CAGR
36%
Over the last 13 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 5 years is 36%.
